scorecardresearch
Add as a preferred source on Google
Thursday, April 16, 2026
TopicPharma industry

Topic: pharma industry

Chhindwara’s Coldrif deaths show India’s dangerous irony—pharmacy of the world, failing at home

India’s pharmaceutical sector is valued at $50 billion. It has built its reputation on affordability and accessibility. The deaths in Chhindwara tell a different story.

Indian drugmakers relieved but wary as US exempts pharma sector from new trade tariffs

Industry insiders say any rise in duties on Indian generics will squeeze profits for Indian companies, but will also make the drugs costlier for patients in US.

Don’t let foreign big pharma block biosimilars. Govt should boost access in India

Without widespread access to biosimilars, thousands of cancer patients are losing their battle. Life-saving treatment is not a privilege but a right. The government should understand this.

Alliance of India’s 26 top drugmakers opposes generic drug substitution at Janaushadhi Kendras

Leading drugmakers express apprehension over CDSCO’s proposal to permit generic alternatives for key medications, emphasizing the risk of compromised drug quality.

SubscriberWrites: Pharma industry – Yearning for reforms

Despite the critical importance of the Pharma Industry, no attempts were made to resolve the issues & transform the industry.

Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat

New Delhi: On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the world, received form 483,...

Tirzepatide, another diabetes drug cleared for weight loss in US, yet to get regulator nod in India

In clinical trials, tirzepatide by Eli Lilly has shown to reduce body weight by up to 22.5 percent, on average, after about 72 weeks, according to the company.

No dent in Indian pharma exports despite quality concerns over cough syrups, data shows

WHO may be probing allegations of 20 substandard paracetamol & cough syrups by 15 manufacturers from India, but these allegations seem to have little impact on export of medicines.

Modi govt likely to bring in stricter pan-Indian system to recall substandard drugs from market

Provision included in draft bill to be approved by Union cabinet. Existing drugs law mentions product recall, but doesn't specify timelines or system for auditing and accountability.

Mandatory test for Indian pharma products in Gambia after cough syrup deaths

The new rule focusses on accessing Gambia's reliance on India's $42 billion pharmaceutical industry since the contamination came to light last year.

On Camera

Avalanche, enemy fire, and a strategy—how Indian Army took control of Siachen

The force for the operation was to be maintained by air through para drops by fixed wing aircrafts while the helicopter effort was primarily earmarked for tasks such as reconnaissance.

Russia raking in a windfall from Hormuz blockade. Export revenues doubled to $19 bn in March, says IEA

Despite damage to key Russian oil infrastructure by Ukrainian drone strikes in March, International Energy Agency data shows Russia’s earnings in March were highest for any month since January 2024.

Why Siliguri Corridor is strategically important for India & how it is being secured | Cut The Clutter

This special edition of Cut The Clutter, straight from the Siliguri corridor, details the strategic importance of the narrow strip of land in West Bengal, and how it’s a vital link connecting the Northeast to the rest of India.

The world’s in a flux. India must reform, consolidate & build a strong economy

We now live in a world order that will keep shifting. India must use this window. This also means we remain disciplined enough not to be knee-jerked into reacting to what Pakistan sees as its moment in the sun.